Greg Otterson: Clinical Trials

1 trial sponsored by Greg Otterson, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Greg Otterson: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, protein expression analysis - Lung Cancer
Phase 2CompletedGreg Otterson632008-08-142018-04-02

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)

Interventions

Carboplatin (1)  ·  Immunoenzyme Techniques (1)  ·  Immunohistochemistry (1)  ·  Taxes (1)

Countries

United States (1)

Top investigators

Gregory A. Otterson, MD (1)

Results publications

PMID 26123189, PMID 31319977